Incidence and outcomes among patients with HR+/HER2- metastatic breast cancer (mBC) with co-occurring ESR1 and PIK3CA mutations detected by ctDNA and treated with alpelisib: A retrospective review.
Publication Date
6-2-2023
Presented At:
ASCO
Content Type
Poster
Citation
Chamorro, Yolcar; Sandoval Leon, Ana; Ahluwalia, Manmeet; Mahtani, Reshma; and Dempsey, Naomi, "Incidence and outcomes among patients with HR+/HER2- metastatic breast cancer (mBC) with co-occurring ESR1 and PIK3CA mutations detected by ctDNA and treated with alpelisib: A retrospective review." (2023). All Publications. 4970.
https://scholarlycommons.baptisthealth.net/se-all-publications/4970